Granted Patent
B2
US 9,540,330 · App. 13/994,606 · Granted Jan 10, 2017
Oligomer-containing hydantoin compounds
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention relates to (among other things) oligomer-containing hydantoin compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
Claims (6)
1. A pharmaceutical composition comprising a compound of formula:
and pharmaceutically acceptable salts thereof, wherein:
n is 1 to 12; and
the compound is present in a dosage form.
2. The pharmaceutical composition of claim 1 , further comprising a pharmaceutically acceptable excipient.
3. The pharmaceutical composition of claim 1 , wherein n is 1 or 3-9.
Assignments (5)
RELEASE OF SECURITY INTEREST
Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 31217, FRAME 0776
Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036876/0130 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS
Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 22, 2014
From: RIGGS-SAUTHIER, JENNIFER; ALLUMS-DONALD, STEPHANIE
To: NEKTAR THERAPEUTICS
Reel/Frame 032730/0300 →
SECURITY AGREEMENT
Recorded Sep 16, 2013
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 031217/0776 →